Discovery of a new anilino-3H-pyrrolo[3,2-f]quinoline derivative as potential anti-cancer agent

European Journal of Medicinal Chemistry
2008.0

Abstract

The newly synthesized 1-[4-(3H-pyrrolo[3,2-f]quinolin-9-ylamino)-phenyl]-ethanone hydrochloride showed high antiproliferative activity by mixed mechanisms of action. The compound acts by forming an intercalative complex with DNA and inhibiting DNA topoisomerase II (topo II) and by blocking the cell cycle in G(2)/M phase. Probable cell death by apoptosis is also suggested by flow cytometry analysis.

Knowledge Graph

Similar Paper

Discovery of a new anilino-3H-pyrrolo[3,2-f]quinoline derivative as potential anti-cancer agent
European Journal of Medicinal Chemistry 2008.0
Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison
European Journal of Medicinal Chemistry 2021.0
Synthesis and biological evaluation of pyrroloiminoquinone derivatives
Bioorganic & Medicinal Chemistry 2008.0
Novel benzoquinoline derivatives via unpredicted condensation of ethyl propiolate and naphthylamines: Synthesis and topoisomerase inhibition activity
Bioorganic & Medicinal Chemistry Letters 2016.0
Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors
European Journal of Medicinal Chemistry 2018.0
DNA-targeting pyrroloquinoline-linked butenone and chalcones: Synthesis and biological evaluation
European Journal of Medicinal Chemistry 2009.0
Design, synthesis and biological evaluation of 1,4-dihydroxyanthraquinone derivatives as anticancer agents
Bioorganic & Medicinal Chemistry Letters 2019.0
Benzoquinazoline derivatives as new agents affecting DNA processing
Bioorganic & Medicinal Chemistry 2011.0
The antitumor activity of novel pyrazoloquinoline derivatives
Bioorganic & Medicinal Chemistry Letters 1995.0
Synthesis and Mechanism Studies of 1,3-Benzoazolyl Substituted Pyrrolo[2,3-b]pyrazine Derivatives as Nonintercalative Topoisomerase II Catalytic Inhibitors
Journal of Medicinal Chemistry 2016.0